Alan F. Denenberg
Lawyers
Filters
Alector $75 million stock offering
The common stock is listed on the Nasdaq Global Select Market
Olema Pharmaceuticals $150 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
Credo Technology Group Holding $201.3 million follow-on offering
We advised Credo on the SEC-registered offering
Uber $1.725 billion convertible notes offering and capped call transactions
The 0.875% convertible senior notes are due 2028
Alector $125 million at-the-market offering
The common stock is listed on the Nasdaq Global Select Market
NeuroPace $50 million at-the-market offering
The stock is listed on the Nasdaq Global Market
IDEAYA Biosciences $143.8 million equity offering
The common stock is listed on the Nasdaq Global Select Market
UCT acquisition of HIS Innovations Group
We advised UCT on the acquisition
Aligos Therapeutics $92 million private placement
The PIPE included common stock and warrants
HilleVax $115 million follow-on offering
The shares are listed on the Nasdaq Global Select Market